The World RNA Series is committed to delivering the most comprehensive portfolio of industry-dedicated forums, exclusively focusing on the specific challenges faced by each community of RNA and mRNA drug developers.
The goal for this event series is to provide your team with the platform to connect, learn and fast-track first- and best-in class therapeutics and vaccines to capitalize on the curative potential of RNA-targeting and RNA-based approaches, accelerating their clinical and commercial development to meet the needs of patients globally.
-
Industry
-
Biotechnology Research
-
Company size
-
201-500 employees
-
Specialties
-
mRNA, RNA, RNA Therapeutics, RNA Vaccines, mRNA Vaccines, Networking, mRNA Therapeutics, mRNA Analytical Development, mRNA Process Development, mRNA Manufacturing, mRNA Assay, RNA-Targeted Drug Discovery, Next Generation RNA Therapeutics, RNA Editing, and mRNA Quality Control